These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 25958305)

  • 41. 5-Substituted-2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]pyrimidines-acyclic nucleoside phosphonate analogues with antiviral activity.
    Hocková D; Holý A; Masojídková M; Andrei G; Snoeck R; De Clercq E; Balzarini J
    J Med Chem; 2003 Nov; 46(23):5064-73. PubMed ID: 14584956
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and antiviral activity evaluation of acyclic 2'-azanucleosides bearing a phosphonomethoxy function in the side chain.
    Koszytkowska-Stawińska M; De Clercq E; Balzarini J
    Bioorg Med Chem; 2009 Jun; 17(11):3756-62. PubMed ID: 19442526
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gene silencing of HIV chemokine receptors using ribozymes and single-stranded antisense RNA.
    Qureshi A; Zheng R; Parlett T; Shi X; Balaraman P; Cheloufi S; Murphy B; Guntermann C; Eagles P
    Biochem J; 2006 Mar; 394(Pt 2):511-8. PubMed ID: 16293105
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel mutation (K70E) in human immunodeficiency virus type 1 reverse transcriptase confers decreased susceptibility to 9-[2-(phosphonomethoxy)ethyl]adenine in vitro.
    Cherrington JM; Mulato AS; Fuller MD; Chen MS
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2212-6. PubMed ID: 8878611
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The synthesis and antiviral properties of acyclic nucleoside analogues with a phosphonomethoxy fragment in the side chain.
    Khandazhinskaya A; Yasko M; Shirokova E
    Curr Med Chem; 2006; 13(24):2953-80. PubMed ID: 17073640
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Coreceptor competition for association with CD4 may change the susceptibility of human cells to infection with T-tropic and macrophagetropic isolates of human immunodeficiency virus type 1.
    Lee S; Lapham CK; Chen H; King L; Manischewitz J; Romantseva T; Mostowski H; Stantchev TS; Broder CC; Golding H
    J Virol; 2000 Jun; 74(11):5016-23. PubMed ID: 10799575
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Brain-derived neurotrophic factor modulates expression of chemokine receptors in the brain.
    Ahmed F; Tessarollo L; Thiele C; Mocchetti I
    Brain Res; 2008 Aug; 1227():1-11. PubMed ID: 18588860
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antiviral activities of novel 5-phosphono-pent-2-en-1-yl nucleosides and their alkoxyalkyl phosphonoesters.
    Choo H; Beadle JR; Kern ER; Prichard MN; Keith KA; Hartline CB; Trahan J; Aldern KA; Korba BE; Hostetler KY
    Antimicrob Agents Chemother; 2007 Feb; 51(2):611-5. PubMed ID: 17130297
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains.
    Huang L; Bosch I; Hofmann W; Sodroski J; Pardee AB
    J Virol; 1998 Nov; 72(11):8952-60. PubMed ID: 9765440
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression and use of human immunodeficiency virus type 1 coreceptors by human alveolar macrophages.
    Worgall S; Connor R; Kaner RJ; Fenamore E; Sheridan K; Singh R; Crystal RG
    J Virol; 1999 Jul; 73(7):5865-74. PubMed ID: 10364338
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A multi-targeted drug candidate with dual anti-HIV and anti-HSV activity.
    Balzarini J; Andrei G; Balestra E; Huskens D; Vanpouille C; Introini A; Zicari S; Liekens S; Snoeck R; Holý A; Perno CF; Margolis L; Schols D
    PLoS Pathog; 2013; 9(7):e1003456. PubMed ID: 23935482
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activities of acyclic nucleoside phosphonates against Orf virus in human and ovine cell monolayers and organotypic ovine raft cultures.
    Dal Pozzo F; Andrei G; Holy A; Van Den Oord J; Scagliarini A; De Clercq E; Snoeck R
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4843-52. PubMed ID: 16304144
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antiretrovirus activity of a novel class of acyclic pyrimidine nucleoside phosphonates.
    Balzarini J; Pannecouque C; De Clercq E; Aquaro S; Perno CF; Egberink H; Holý A
    Antimicrob Agents Chemother; 2002 Jul; 46(7):2185-93. PubMed ID: 12069973
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antivaccinia activities of acyclic nucleoside phosphonate derivatives in epithelial cells and organotypic cultures.
    Snoeck R; Holý A; Dewolf-Peeters C; Van Den Oord J; De Clercq E; Andrei G
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3356-61. PubMed ID: 12384336
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemokine receptor regulation and HIV type 1 tropism in monocyte-macrophages.
    Di Marzio P; Tse J; Landau NR
    AIDS Res Hum Retroviruses; 1998 Jan; 14(2):129-38. PubMed ID: 9462923
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cellular expression of functional chemokine receptor CCR5 and CXCR4 in human embryonic neurons.
    Boutet A; Salim H; Leclerc P; Tardieu M
    Neurosci Lett; 2001 Sep; 311(2):105-8. PubMed ID: 11567789
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Agonist-induced internalization of CC chemokine receptor 5 as a mechanism to inhibit HIV replication.
    Ferain T; Hoveyda H; Ooms F; Schols D; Bernard J; Fraser G
    J Pharmacol Exp Ther; 2011 Jun; 337(3):655-62. PubMed ID: 21389095
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Extent of intramolecular π-stacks in aqueous solution in mixed-ligand copper(II) complexes formed by heteroaromatic amines and several 2-aminopurine derivatives of the antivirally active nucleotide analog 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA).
    Gómez-Coca RB; Blindauer CA; Sigel A; Operschall BP; Holý A; Sigel H
    Chem Biodivers; 2012 Sep; 9(9):2008-34. PubMed ID: 22976988
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acyclic nucleotide analogs derived from 8-azapurines: synthesis and antiviral activity.
    Holý A; Dvoráková H; Jindrich J; Masojídková M; Budĕsínský M; Balzarini J; Andrei G; De Clercq E
    J Med Chem; 1996 Sep; 39(20):4073-88. PubMed ID: 8831773
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 9-[2-(R)-(Phosphonomethoxy)propyl]-2,6-diaminopurine (R)-PMPDAP and its prodrugs: optimized preparation, including identification of by-products formed, and antiviral evaluation in vitro.
    Krečmerová M; Jansa P; Dračínský M; Sázelová P; Kašička V; Neyts J; Auwerx J; Kiss E; Goris N; Stepan G; Janeba Z
    Bioorg Med Chem; 2013 Mar; 21(5):1199-208. PubMed ID: 23375089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.